Albertsons Companies, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Albertsons Companies, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2021	FY2022	FY2022	FY2023	FY2024	FY2025
Revenue	59,678	59,925	60,535	62,455	69,690	71,887	77,650	79,238	80,391	83,173
Cost of revenue	43,038	43,564	43,640	44,861	49,276	51,165	55,894	57,192	58,135	60,566
Gross profit	16,641	16,361	16,895	17,594	20,415	20,722	21,756	22,046	22,256	22,607
Selling, general and administrative	16,033	16,209	16,272	16,642	18,836	18,301	19,596	19,933	20,614	21,891
Operating income	608	-56.6	787	1,437	1,618	2,437	2,307	2,069	1,546	728
Interest expense	764	702	698	565	463	400	405	447	415	455
Other non-operating income	44.3	9.2	104	-28.5	135	148	33	12.2	43.4	44.4
Pre-tax income	-464	-918	52.2	599	1,129		1,936	1,589	1,130	268
Income tax	-90.3	-964	-78.9	133	279	480	422	293	171	50.4
Income from continuing operations		-918	52.2	599	1,129	2,100	1,936	1,589
Net income	-373	46.3	131	466	850	1,620	1,514	1,296	959	217
EBITDA	1,853	1,274	2,045	3,128	3,154	4,118	4,114	3,848	3,364	2,641
EPS, basic		0.08	0.23	0.80	1.53	2.73	2.29	2.25	1.65	0.40
EPS, diluted		0.08	0.23	0.80	1.47	2.70	2.27	2.23	1.64	0.40
Shares, basic (weighted)		580	581	579	500	470	529	575	580	545
Shares, diluted (weighted)		580	581	580	578	475	534	581	584	547
Dividend per share					0.20	0.44	0.48	0.48	0.51	0.60

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2021	FY2022	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	1,219	670	926	471	1,717	2,902	456	189	294	199
Receivables	631	615	586	525	551	561	688	724	835	933
Inventory	4,464	4,421	4,333	4,353	4,301	4,501	4,782	4,945	4,989	5,174
Other current assets	134	73.3	88.7	128	102	101	42.3	58.9	103	411
Total current assets	6,793	6,149	6,250	5,731	6,988	8,366	6,270	6,288	6,559	6,716
Property, plant and equipment	11,512	10,770	9,861	9,212	9,413	9,350	9,359	9,570	9,811	9,904
Lease right-of-use assets				5,867	6,016	5,908	5,879	5,982	6,153	6,102
Goodwill	1,168	1,183	1,183	1,183	1,183	1,201	1,201	1,201	1,201	1,201
Intangible assets	3,498	3,143	2,835	2,087	2,109	2,285	2,465	2,435	2,318	2,156
Other non-current assets	784	568	648	654	890	1,013	994	746	713	687
Total assets	23,755	21,812	20,777	24,735	26,598	28,123	26,168	26,221	26,756	26,766
Accounts payable	3,035	2,833	2,919	2,891	3,487	4,237	4,173	4,218	4,093	4,021
Short-term debt	204	66.1	51.5	221	212	829	1,076	285	57.6	534
Total current liabilities	5,741	5,030	5,153	5,904	6,832	8,349	8,429	7,458	7,251	7,824
Long-term debt	11,180	10,945	9,773	8,493	8,101	7,136	7,834	7,783	7,763	8,413
Lease liabilities				5,403	5,548	5,420	5,386	5,493	5,657	5,614
Other non-current liabilities	2,172	2,175	2,335	1,204	1,822	1,278	1,130	1,032	953	2,449
Total liabilities		20,414	19,326	22,457	25,274	25,098	24,558	23,474	23,370	24,930
Total debt	11,384	11,011	10,586	8,715	8,314	7,965	8,910	8,069	7,820	8,947
Paid-in capital		1,773	1,811	1,824	1,899	2,032	2,073	2,130	2,184	2,219
Retained earnings	-615	-569	-432	592	1,263	2,565	-185	828	1,488	1,378
Treasury stock		0	-25.8	-25.8	-1,907	-1,647	-352	-304	-387	-1,851
Other comprehensive income	-12.8	191	91.3	-119	63.5	69	69.3	88	94.7	83.2
Shareholders' equity		1,398	1,451	2,278	1,324	3,025	1,611	2,748	3,386	1,836
Total equity		1,398	1,451	2,278	1,324	3,025	1,611	2,748	3,386	1,836
Total liabilities and equity	23,755	21,812	20,777	24,735	26,598	28,123	26,168	26,221	26,756	26,766
Shares outstanding		280	278	278

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2021	FY2022	FY2022	FY2023	FY2024	FY2025
Net income	-373	46.3	131	466	850	1,620	1,514	1,296	959	217
Depreciation and amortization	1,246	1,331	1,258	1,691	1,537	1,681	1,807	1,779	1,818	1,914
Stock-based compensation	53.3	45.9	47.7	32.8	59	101	138	105	106	95.5
Deferred income tax	-220	-1,094	-81.5	-5.9	-112	219	12.9	-113	-105	-209
Change in receivables	-9.2	21.7	28.8	60.8	0.4	-22.4	-127	-36.3	-114	-96.9
Change in inventory	2.7	45.6	80.3	-38.1	9.2	-314	-549	-215	-72.4	-251
Change in payables	234	-158	98.4	85.3	787	680	-164	101	-170	12.8
Cash from operations	1,814	1,019	1,688	1,904	3,903	3,513	2,854	2,660	2,681	2,367
Capital expenditures	-1,376	-1,521	-1,344	-1,467	-1,643	-1,607	-2,154	-2,031	-1,931	-1,839
Acquisitions	-221	-149	0	0	-97.9	-25.4	0	0
Cash from investing	-1,080	-469	-86.8	-379	-1,572	-1,539	-1,977	-1,747	-1,892	-1,679
Debt issued	3,053	290	1,970	3,874	4,094	0	2,150	150	50	4,672
Debt repaid	-2,833	-871	-3,082	-5,677	-4,447	-331	-1,151	-951	-251	-3,511
Share buybacks	0	0	-25.8	0	-1,881	0	0	0	-82.5	-1,478
Dividends paid			0	0	-93.7	-207	-255	-276	-295	-323
Cash from financing	-97.8	-1,098	-1,314	-2,014	-1,042	-790	-3,365	-1,183	-684	-782
Net change in cash	636	-548	287	-489	1,289	1,185	-2,489	-271	105	-94.9
Free cash flow	438	-502	344	437	2,259	1,907	700	628	749	527
Interest paid	924	814	806	719	574	480	395	484	444	448
Income taxes paid	129	15.8	18.2	229	366	241	221	405	168	256

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $11.67 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	27.2%	Gross profit / revenue.
Operating margin	0.9%	Operating income / revenue.
EBITDA margin	3.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	0.3%	Pre-tax income / revenue.
Net margin	0.3%	Net income / revenue.
FCF margin	0.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	2.8%	Cash from operations / revenue.
Effective tax rate	18.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.8%	Net income / average total assets.
Return on invested capital (ROIC)	5.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	26.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.2%	Capital expenditures / revenue.
D&A / revenue	2.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	1.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	1.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	2.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-52.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-31.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-14.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-21.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-13.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-3.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-77.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-47.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-23.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-75.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-43.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-22.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-11.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-6.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-9.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-29.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-9.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-25.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	17.6%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	7.7%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	24.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-45.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	6.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-6.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.86x	Current assets / current liabilities.
Quick ratio	0.14x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.03x	(Cash + short-term investments) / current liabilities.
Debt / equity	4.87x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	33.4%	Total debt / total assets.
Liabilities / assets	93.1%	Total liabilities / total assets.
Net debt	$8.75B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.31x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.60x	Operating income / interest expense.
Working capital	-$1.11B	Current assets - current liabilities.
Goodwill and intangibles / assets	12.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.52B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	3.11x	Revenue / average total assets.
Fixed asset turnover	8.44x	Revenue / average property, plant and equipment.
Inventory turnover	11.9x	Cost of revenue / average inventory.
Days inventory	31 days	365 x average inventory / cost of revenue.
Receivables turnover	94.1x	Revenue / average receivables.
Days sales outstanding	4 days	365 x average receivables / revenue.
Days payables	24 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	10 days	Days inventory + days sales outstanding - days payables.
FCF conversion	242.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	77.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.40	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.40	Net income per basic share, as reported (split-adjusted).
Revenue per share	$152.00	Revenue / diluted weighted shares.
FCF per share	$0.96	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.33	Cash from operations / diluted weighted shares.
Book value per share	$3.36	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$2.78	Tangible book value / shares outstanding.
Cash per share	$0.36	(Cash + short-term investments) / shares outstanding.
Dividend per share	$0.60	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	148.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	61.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	280.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.66B	Share price x shares outstanding.
Enterprise value	$14.41B	Market cap + total debt - cash - short-term investments.
P/E	26.1x	Market cap / net income. Only when net income is positive.
P/S	0.07x	Market cap / revenue.
P/B	3.08x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	10.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.39x	Market cap / cash from operations, when positive.
EV/Sales	0.17x	Enterprise value / revenue.
EV/EBIT	19.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.46x	Enterprise value / EBITDA, when both are positive.
EV/FCF	27.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.3%	Free cash flow / market cap.
Earnings yield	3.8%	Net income / market cap (the inverse of P/E).
Dividend yield	5.7%	Dividends paid over the period / market cap.
Shareholder yield	31.8%	(Dividends paid + share buybacks) / market cap.

What was Albertsons Companies, Inc.'s revenue in fiscal 2025?

Albertsons Companies, Inc. reported revenue of $83.17B for fiscal 2025, 3.5% higher than the year before.

Was Albertsons Companies, Inc. profitable in fiscal 2025?

Yes. Net income was $217.4M, a net margin of 0.3%.

How much free cash flow did Albertsons Companies, Inc. generate in fiscal 2025?

Cash from operations of $2.37B minus capital expenditures of $1.84B left free cash flow of $527.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Albertsons Companies, Inc.